In this paper, results on spectrally negative Lévy processes are used to study the ruin probability under some risk processes. These processes include the compound Poisson process and the gamma process, both perturbed by diffusion. In addition, the first time the risk process hits a given level is also studied. In the case of classical risk process, the joint distribution of the ruin time and the first recovery time is obtained. Some results in this paper have appeared before (e.g., Dufresne and Gerber (1991), Gerber (1990), dos Reis (1993)). We revisit them from the Lévy process theory's point of view and in a unified and simple way.
We derive expressions for the density of the time to ruin given that ruin occurs in a Sparre Andersen model in which individual claim amounts are exponentially distributed and inter-arrival times are distributed as Erlang(n, β). We provide numerical illustrations of finite time ruin probabilities, as well as illustrating features of the density functions.
This paper considers a correlated aggregate claims model with common Poisson shocks, which allows for dependence in n (n ≥ 2) classes of business across m (m ≥ 1) different types of stochastic events. The dependence structure between different claim numbers is connected with the thinning procedure. Under combination of quota-share and excess of loss reinsurance arrangements, we examine the properties of the proposed risk model. An upper bound for the ruin probability determined by the adjustment coefficient is established through martingale approach. We reduce the problem of optimal reinsurance strategy for maximizing the insurer's adjustment coefficient and illustrate the results by numerical examples.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.